Phase 3 Nasopharyngeal Cancinoma (NPC) Clinical Trials
8 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–8 of 8 trials
Recruiting
Phase 3
Reduced-dose vs Standard-dose Irradiation for Low-risk Clinical Target Volume in Nasopharyngeal Carcinoma.
Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University700 enrolled6 locationsNCT07201337
Recruiting
Phase 3
Prevention and Treatment of Radiation-Induced Oral Mucositis in NPC With Houyanqing Oral Liquid
Nasopharyngeal Cancinoma (NPC)Radiation-induced Oral Mucositis
Sun Yat-sen University244 enrolled16 locationsNCT07311772
Recruiting
Phase 3
Phase 3 Trial Comparing IMRT or IMPT Plus CIRT for Patients With NPC
Nasopharyngeal Cancinoma (NPC)
Lin Kong, MD470 enrolled1 locationNCT06846450
Recruiting
Phase 3
Adaptive Immunotherapy for Nasopharyngeal Carcinoma
Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University802 enrolled1 locationNCT07154069
Recruiting
Phase 3
QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma.
Nasopharyngeal CancerNasopharyngeal Cancinoma (NPC)
Sun Yat-Sen University Cancer Center580 enrolled19 locationsNCT06749899
Recruiting
Phase 3
Reduced Dose Radiotherapy vs Standard Dose Radiotherapy for Early Stage Nasopharyngeal Carcinoma
Nasopharyngeal Cancinoma (NPC)
Hai-Qiang Mai,MD,PhD342 enrolled1 locationNCT06912698
Recruiting
Phase 2Phase 3
Sodium Bicarbonate for Reducing Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma.
Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University196 enrolled1 locationNCT06854510
Recruiting
Phase 3
Nab-TPC vs GP Combined With Camrelizumab in the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma
Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University242 enrolled1 locationNCT06669611